A study published by Danish researchers on Friday suggests that semaglutide drugs like Wegovy and Ozempic can significantly ...

The majority of weight loss from GLP-1 medication is from fat loss, and not muscle loss, new evidence suggests.

U.S. President Donald Trump announced on Friday that the federal government is taking steps to expand access to GLP-1 ...

Hershey's gum and mint sales are rising as GLP-1 weight-loss drug users seek relief from side effects like 'Ozempic breath'.

Company positions itself as the central research hub for patients, clinicians, and compounding pharmacies tracking the ...

While GLP-1 medications first gained visibility for diabetes care and later for weight loss, researchers are now evaluating ...

The US FDA has proposed an end to most types of compounding of semaglutide, tirzepatide, and liraglutide. The agency said in a statement it has determined there is no longer a clinical need for ...

The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.

A majority of GLP-1 lawsuits come from patients who allege that manufacturers have inadequately warned about severe side ...

"There was a pendulum that swung that was so body acceptance, positivity, everybody be who they want to be. And now it's ...

As many of us know, keeping weight in check can be hard. National numbers certainly reflect this. Rates of overweight and ...

While CEO Kirk Tanner didn't specify the connection, GLP-1 drug users have documented an unofficial side effect commonly ...